Advertisement

Diabetologia

, Volume 37, Issue 9, pp 948–952 | Cite as

Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease

  • G. M. Reaven
  • A. Laws
For Debate

Keywords

Public Health Internal Medicine Heart Disease Insulin Resistance Coronary Heart Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

CHD

Coronary heart disease

TG

triglyceride

PAI-1

plasminogen-activator inhibitor-1

References

  1. 1.
    Jarrett RJ (1994) Why is insulin not a risk factor for coronary heart disease? Diabetologia 37: 945–947PubMedGoogle Scholar
  2. 2.
    Stout RW (1990) Insulin and atheroma: 20-yr perspective. Diabetes Care 13: 631–654PubMedGoogle Scholar
  3. 3.
    Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1495–1607Google Scholar
  4. 4.
    Hollenbeck G, Reaven GM (1987) Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 64: 1169–1173PubMedGoogle Scholar
  5. 5.
    Reaven GM, Hollenbeck CB, Chen Y-DI (1989) Relationship between glucose tolerance, insulin secretion, and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 32: 52–55CrossRefPubMedGoogle Scholar
  6. 6.
    Reaven GM, Brand RJ, Chen Y-DI, Mathur AK, Goldfine I (1993) Insulin resistance and insulin secretion are determinants of oral glucose tolerance in normal individuals. Diabetes 42: 1324–1332PubMedGoogle Scholar
  7. 7.
    Haffner SM, Stem MP, Hazuda HP, Mitchell BD, Patterson JK (1990) Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? J Amer Med Assoc 263: 2893–2898CrossRefGoogle Scholar
  8. 8.
    Landin K, Tengvory L, Smith U (1990) Elevated fibrinogen and plasminogen activator (PAI-1) in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med 227: 273–278PubMedGoogle Scholar
  9. 9.
    Ferrannini E, Haffner SM, Mitchell BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 3: 416–422Google Scholar
  10. 10.
    Laws A, Reaven GM (1993) Insulin resistance and risk factors for coronary heart disease. In: Ferrannini E (ed) Clinical endocrinology and metabolism: insulin resistance and disease. Baillière Tindall, London, pp 1063–1078Google Scholar
  11. 11.
    Reaven GM, Chen Y-DI (1988) Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes/Metab Rev 4: 639–652Google Scholar
  12. 12.
    Reaven GM, Lerner RL, Stern MP, Farquhar JW (1967) Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 46: 1756–1767PubMedGoogle Scholar
  13. 13.
    Olefsky JM, Farquhar JW, Reaven GM (1974) Reappraisal of the role of insulin in hypertriglyceridemia. Am J Med 57: 551–560CrossRefPubMedGoogle Scholar
  14. 14.
    Tobey TA, Greenfield M, Kraemer F, Reaven GM (1981) Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30: 165–171CrossRefPubMedGoogle Scholar
  15. 15.
    Garg A, Helderman JH, Koffler M, Ayuso R, Rosenstack J, Raskin P (1988) Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 37: 982–987PubMedGoogle Scholar
  16. 16.
    Olefsky JM, Reaven GM, Farquhar JW (1974) Effects of weight reduction on obesity: studies of carbohydrate and lipid metabolism, J Clin Invest 53: 64–76PubMedGoogle Scholar
  17. 17.
    Farquhar JW, Frank A, Gross RC, Reaven GM (1966) Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man. J Clin Invest 45: 1648–1656PubMedGoogle Scholar
  18. 18.
    Zavaroni I, Dall'Aglio E, Alpi O et al. (1985) Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55: 259–266PubMedGoogle Scholar
  19. 19.
    Laws A, Reaven GM (1992) Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. J Int Med 231: 25–30Google Scholar
  20. 20.
    Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WS, Krauss RM (1988) Low-density lipoprotein subclass patterns and risk of myocardial infarction. J Am Med Assoc 260: 1917–1921CrossRefGoogle Scholar
  21. 21.
    Patsch JR, Miesenböck G, Hopferwieser T et al. (1992) Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb 12: 1336–1345PubMedGoogle Scholar
  22. 22.
    Reaven GM, Chen Y-DI, Jeppesen J, Maheux P, Krauss RM (1993) Insulin resistance and hyperinsulinemia in individuals with small, dense, low density lipoprotein particles. J Clin Invest 92: 141–146PubMedGoogle Scholar
  23. 23.
    Chen Y-DI, Swami S, Skowronski R, Coulston A, Reaven GM (1993) Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 76: 172–177CrossRefPubMedGoogle Scholar
  24. 24.
    Miller GJ, Miller NE (1975) Plasma-high-density-lipoprotein concentration and development of ischaemic heartdisease. Lancet I: 16–19CrossRefGoogle Scholar
  25. 25.
    Castelli WP, Doyle JT, Gordon T et al. HDL cholesterol and other lipids in coronary heart disease. Circulation 55: 767–772Google Scholar
  26. 26.
    Manninen V, Tenkanen L, Koskinen P et al. (1992) Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki heart study: implications for treatment. Circulation 85: 37–45PubMedGoogle Scholar
  27. 27.
    Assmann G, Schulte H (1992) Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol 70: 733–737CrossRefPubMedGoogle Scholar
  28. 28.
    Hulley SB, Rosenman RH, Bawol RD, Brand RJ (1980) Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med 302: 1383–1389PubMedGoogle Scholar
  29. 29.
    Criqui MH, Heiss G, Cohn R et al. (1993) Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 328: 1220–1225CrossRefPubMedGoogle Scholar
  30. 30.
    Austin MA (1991) Plasma triglyceride and coronary heart disease. Arterioscler Thromb 11: 2–14PubMedGoogle Scholar
  31. 31.
    Reaven GM (1993) Are triglycerides important as a risk factor for coronary disease? Heart Dis Stroke 2: 44–48PubMedGoogle Scholar
  32. 32.
    Laws A, King AC, Haskell W, Reaven GM (1991) Relation of fasting plasma insulin concentration to high density lipoprotein cholesterol and triglyceride concentrations in men. Arterioscler Thromb 11: 1636–1642PubMedGoogle Scholar
  33. 33.
    Juhan-Vague I, Alessi MC, Vague P (1991) Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis. Diabetologia 34: 457–462PubMedGoogle Scholar
  34. 34.
    Potter van Loon BJ, Kluft C, Radder JK, Blankenstein MA, Meinders AE (1993) The cardiovascular risk factor plasminogen activator inhibitor type I is related to insulin resistance. Metabolism 42: 945–949CrossRefPubMedGoogle Scholar
  35. 35.
    Juhan-Vague I, Thompson SG, Jespersen J, on Behalf of the ECAT Angina Pectoris Study Group (1993) Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1500 patients with angina pectoris. Arterioscler Thromb 13: 1865–1873PubMedGoogle Scholar
  36. 36.
    Hamsten A, Wiman B, Defaire U, Blomback M (1985) Increased plasma level of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 313: 1557–1563PubMedGoogle Scholar
  37. 37.
    Jarrett RJ (1992) In defence of insulin: a critique of syndrome X. Lancet 340: 469–471CrossRefPubMedGoogle Scholar
  38. 38.
    Reaven GM (1991) Relationship between insulin resistance and hypertension. Diabetes Care 14: 33–38PubMedGoogle Scholar
  39. 39.
    Ferrari P, Weidmann P, Shaw S et al. (1991) Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med 91: 589–596CrossRefPubMedGoogle Scholar
  40. 40.
    Facchini F, Chen Y-DI, Clinkingbeard C, Jeppesen J Reaven GM (1992) Insulin resistance, hyperinsulinemia, and dyslipidemia in nonobese individuals with a family history of hypertension. Am J Hypertens 5: 694–699Google Scholar
  41. 41.
    Shamiss A, Carroll J, Rosenthal T (1992) Insulin resistance in secondary hypertension. Am J Hypertens 5: 26–28PubMedGoogle Scholar
  42. 42.
    Hwang I-S, Ho H, Hoffmann BB, Reaven GM (1987) Fructose-induced insulin and hypertension in rats. Hypertension 10: 512–516PubMedGoogle Scholar
  43. 43.
    Reaven GM, Ho H, Hoffman BB (1988) Attenuation of fructose-induced hypertension in rats by exercise training. Hypertension 12: 129–132PubMedGoogle Scholar
  44. 44.
    Reaven GM, Ho H, Hoffmann BB (1989) Somatostatin inhibition of fructose-induced hypertension. Hypertension 14: 117–120PubMedGoogle Scholar
  45. 45.
    Reaven GM, Chang H (1991) Relationship between blood pressure, insulin concentration, and insulin action in SHR and WKY rats. Am J Hypertens 4: 34–38PubMedGoogle Scholar
  46. 46.
    Reaven GM, Twersky J, Chang H (1991) Abnormalities of carbohydrate and lipid metabolism in Dahl rats. Hypertension 18: 630–635PubMedGoogle Scholar
  47. 47.
    Dall'Aglio E, Tosini P, Ferrari P, Zavaroni I, Passeri M, Reaven GM (1991) Abnormalities of insulin and lipid metabolism in Milan hypertensive rats. Am J Hypertens 4: 773–775PubMedGoogle Scholar
  48. 48.
    Anderson EA, Mark AL (1993) The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension 21: 136–141PubMedGoogle Scholar
  49. 49.
    Hall JE, Brands MW, Kivlighn SD, Mizelle HL, Hildebrandt A, Gaillard CA (1990) Chronic hyperinsulinemia and blood pressure. Hypertension 15: 519–527PubMedGoogle Scholar
  50. 50.
    Brands MW, Hildebrandt DA, Mizelle HL, Hall JE (1991) Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol 260: R764-R768PubMedGoogle Scholar
  51. 51.
    Saad M, Lillioja S, Myomba BL et al. (1991) Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 324: 733–739PubMedGoogle Scholar
  52. 52.
    Falkner B, Hulman S, Tennenbaum J, Kushner H (1990) Insulin resistance and blood pressure in young black men. Hypertension 16: 706–711PubMedGoogle Scholar
  53. 53.
    Falkner B, Hulman S, Kushner H (1993) Insulin-stimulated glucose utilization and borderline hypertension in young adult blacks. Hypertension 22: 18–25PubMedGoogle Scholar
  54. 54.
    Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H (1980) Coronary-heart-disease risk and impaired glucose tolerance. Lancet i: 1373–1376Google Scholar
  55. 55.
    Vaccaro O, Ruth KJ, Stamler J (1992) Relationship of postload plasma glucose to mortality with 19-yr follow-up. Diabetes Care 13: 1328–1334Google Scholar
  56. 56.
    Sheu WH-H, Jeng C-Y, Shieh S-M et al. (1992) Insulin resistance and abnormal electrocardiograms in patients with high blood pressure. Am J Hypertens 5: 444–448PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • G. M. Reaven
    • 1
  • A. Laws
    • 1
  1. 1.Division of Endocrinology, Gerontology and Metabolism, Department of Veterans Affairs Medical CenterStanford University School of MedicinePalo AltoUSA

Personalised recommendations